Sellas Life Sciences Appoints Baker Tilly as New Auditors Following Moss Adams Merger

Reuters
Yesterday
Sellas Life Sciences Appoints Baker Tilly as New Auditors Following Moss Adams Merger

Sellas Life Sciences Group Inc. recently announced a change in its certifying accountants following the merger of its former independent registered public accounting firm, Moss Adams LLP, with Baker Tilly US, LLP. Effective June 3, 2025, Moss Adams resigned as the auditors of the company, and the Audit Committee of Sellas' Board of Directors appointed Baker Tilly as the new independent registered public accounting firm for the fiscal year ending December 31, 2025. The transition occurred without any disagreements or reportable events related to accounting principles or practices. Moss Adams has provided a letter to the Securities and Exchange Commission confirming its agreement with the company's statements regarding the transition.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sellas Life Sciences Group Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-25-057308), on June 06, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10